Wells Fargo & Company Jazz Pharmaceuticals PLC Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Wells Fargo & Company holds 204,126 shares of JAZZ stock, worth $22.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

204,126

Previous 222,358 8.2%

Holding current value

$22.3 Million

Previous $26.8 Million 18.64%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$103.94 - $118.98 $1.9 Million - $2.17 Million	-18,232 Reduced 8.2%	204,126 $21.8 Million
Q1 2024 May 10, 2024	BUY	$115.19 - $132.77 $12.8 Million - $14.8 Million	111,301 Added 100.22%	222,358 $26.8 Million
Q4 2023 Feb 09, 2024	SELL	$114.26 - $136.0 $915,908 - $1.09 Million	-8,016 Reduced 6.73%	111,057 $13.7 Million
Q3 2023 Nov 13, 2023	BUY	$122.0 - $145.31 $2.05 Million - $2.44 Million	16,813 Added 16.44%	119,073 $15.4 Million
Q2 2023 Aug 15, 2023	SELL	$122.5 - $147.16 $57,207 - $68,723	-467 Reduced 0.45%	102,260 $12.7 Million
Q1 2023 May 12, 2023	SELL	$133.98 - $160.47 $257,777 - $308,744	-1,924 Reduced 1.84%	102,727 $15 Million
Q4 2022 Feb 13, 2023	SELL	$129.72 - $159.85 $1.79 Million - $2.2 Million	-13,766 Reduced 11.63%	104,651 $16.7 Million
Q3 2022 Nov 14, 2022	BUY	$126.59 - $161.18 $1.44 Million - $1.84 Million	11,412 Added 10.66%	118,417 $15.8 Million
Q2 2022 Aug 12, 2022	BUY	$141.59 - $168.66 $524,874 - $625,222	3,707 Added 3.59%	107,005 $16.7 Million
Q1 2022 May 16, 2022	BUY	$129.64 - $160.7 $4.38 Million - $5.43 Million	33,770 Added 48.57%	103,298 $16.1 Million
Q4 2021 Feb 14, 2022	SELL	$119.87 - $145.67 $5.25 Million - $6.38 Million	-43,770 Reduced 38.63%	69,528 $8.86 Million
Q3 2021 Nov 15, 2021	BUY	$128.64 - $184.79 $3.51 Million - $5.04 Million	27,250 Added 31.67%	113,298 $14.8 Million
Q2 2021 Aug 16, 2021	SELL	$160.2 - $186.42 $3.47 Million - $4.04 Million	-21,668 Reduced 20.12%	86,048 $15.3 Million
Q1 2021 May 13, 2021	SELL	$150.19 - $173.5 $1.62 Million - $1.87 Million	-10,760 Reduced 9.08%	107,716 $17.7 Million
Q4 2020 Feb 09, 2021	SELL	$140.71 - $165.05 $321,944 - $377,634	-2,288 Reduced 1.89%	118,476 $19.6 Million
Q3 2020 Nov 05, 2020	SELL	$105.46 - $144.13 $19.8 Million - $27.1 Million	-188,050 Reduced 60.89%	120,764 $17.2 Million
Q2 2020 Aug 13, 2020	SELL	$95.68 - $121.88 $3.84 Million - $4.89 Million	-40,115 Reduced 11.5%	308,814 $34.1 Million
Q1 2020 May 14, 2020	BUY	$87.74 - $152.74 $30.6 Million - $53.3 Million	348,929 New	348,929 $34.8 Million

Others Institutions Holding JAZZ

# of Institutions

500

Shares Held

57.4M

Call Options Held

155K

Put Options Held

152K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $6.86B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Jazz Pharmaceuticals PLC Transaction History